Clinical Trial

Intranasal Tranexamic Acid for Anterior Nosebleeds

Study Description

Intranasal TXA for Anterior Epistaxis in the Emergency Department

The objective of this study is to evaluate the efficacy of and patient satisfaction with the use of intranasal tranexamic acid (TXA) for anterior nosebleeds in the emergency department (ED).

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Tranexamic Acid

Enrolled patients will be placed in one of two groups: either the group receiving a cotton pledget soaked in (0.9%) saline or (100mg/1mL) TXA. Patients will initially be asked to gently blow their nose to remove any clots. Group 1 will receive the saline soaked pledget. After fifteen minutes the pledget will be removed. If patient continues to bleed within a reevaluation period of fifteen minutes, this will be deemed a 'failure' and the examiner will pack the nose with the method of his or her c ...read more on ClinicalTrials.org

Placebo

This group will receive pledget soaked in saline. Protocol will continue as with TXA group.

Additional Information

Official Study Title

Intranasal TXA for Anterior Epistaxis in the Emergency Department

Clinical Trial ID

NCT04054687

ParticipAid ID

dwpD1e